217 related articles for article (PubMed ID: 31793373)
1. Effects of Inotropes on the Mortality in Patients With Septic Shock.
Sato R; Ariyoshi N; Hasegawa D; Crossey E; Hamahata N; Ishihara T; Nasu M; Devendra G
J Intensive Care Med; 2021 Feb; 36(2):211-219. PubMed ID: 31793373
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
3. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
4. The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.
Zhu Y; Yin H; Zhang R; Ye X; Wei J
Int J Clin Pract; 2021 Nov; 75(11):e14689. PubMed ID: 34331721
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
Bhattacharjee S; Soni KD; Maitra S; Baidya DK
J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
[TBL] [Abstract][Full Text] [Related]
6. Inotrope Use and Intensive Care Unit Mortality in Patients With Cardiogenic Shock: An Analysis of a Large Electronic Intensive Care Unit Database.
Gao F; Zhang Y
Front Cardiovasc Med; 2021; 8():696138. PubMed ID: 34621796
[No Abstract] [Full Text] [Related]
7. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
8. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
9. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.
Annane D; Vignon P; Renault A; Bollaert PE; Charpentier C; Martin C; Troché G; Ricard JD; Nitenberg G; Papazian L; Azoulay E; Bellissant E;
Lancet; 2007 Aug; 370(9588):676-84. PubMed ID: 17720019
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
[TBL] [Abstract][Full Text] [Related]
12. Association between inotrope treatment and 90-day mortality in patients with septic shock.
Wilkman E; Kaukonen KM; Pettilä V; Kuitunen A; Varpula M
Acta Anaesthesiol Scand; 2013 Apr; 57(4):431-42. PubMed ID: 23298252
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
14. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ
Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650
[TBL] [Abstract][Full Text] [Related]
16. The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study.
Willems A; Havaux R; Schmartz D; Fils JF; DE Pooter F; VAN DER Linden P
Minerva Anestesiol; 2023 Sep; 89(9):753-761. PubMed ID: 37676176
[TBL] [Abstract][Full Text] [Related]
17. [Value of pulse indicator continuous cardiac output monitoring of cardiac function in septic shock patients: a prospective study].
Yi M; Yao G; Guo X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):22-7. PubMed ID: 25591432
[TBL] [Abstract][Full Text] [Related]
18. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
19. Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen.
Joynt C; Bigam DL; Charrois G; Jewell LD; Korbutt G; Cheung PY
Intensive Care Med; 2010 Jun; 36(6):1058-66. PubMed ID: 20221750
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Kelly J; Cheng J; Malloy R; Lupi K
J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
